Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2017 Dec 7;12(12):1911-1913.
doi: 10.2215/CJN.11011017. Epub 2017 Oct 26.

Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD

Rupal Mehta  1   2 , Tamara Isakova  1   2
Affiliations
Editorial

Continued Search for Therapies to Favorably Modify Phosphate and FGF23 Levels in CKD

Rupal Mehta et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Atrial Fibrillation; CKD; Cardiovascular Diseases; Fibroblast Growth Factors; Humans; Hypertrophy, Left Ventricular; Inflammation; Leukocytes; Myocytes, Cardiac; Phosphates; Renal Insufficiency, Chronic; fibroblast growth factor 23; heart failure; hyperphosphatemia; phosphate binders; risk factors.

PubMed Disclaimer

Comment on

References

    1. Scialla JJ, Wolf M: Roles of phosphate and fibroblast growth factor 23 in cardiovascular disease. Nat Rev Nephrol 10: 268–278, 2014 - PubMed
    1. Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA: Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD. J Am Soc Nephrol 26: 2328–2339, 2015 - PMC - PubMed
    1. Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM: Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 23: 1407–1415, 2012 - PMC - PubMed
    1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group : KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl 7: 1–59, 2017 - PMC - PubMed
    1. Liabeuf S, Ryckelynck JP, El Esper N, Urena P, Combe C, Dussol B, Fouque D, Vanhille P, Frimat L, Thervet E, Mentaverri R, Prie D, Choukroun G; for the French Study Collaborators : Clin J Am Soc Nephrol 12: 1930–1940, 2017 - PMC - PubMed